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In mammalian cells, DNA double-strand breaks (DSBs) are primarily repaired by nonhomologous end joining (NHEJ). The
current model suggests that the Ku 70/80 heterodimer binds to DSB ends and recruits DNA-PKcs to form the active DNA-
dependent protein kinase, DNA-PK. Subsequently, XRCC4, DNA ligase IV, XLF and most likely, other unidentiﬁed components
participate in the ﬁnal DSB ligation step. Therefore, DNA-PK plays a key role in NHEJ due to its structural and regulatory
functions that mediate DSB end joining. However, recent studies show that additional DNA-PK-independent NHEJ pathways
also exist. Unfortunately, the presence of DNA-PKcs appears to inhibit DNA-PK-independent NHEJ, and in vitro analysis of DNA-
PK-independent NHEJ in the presence of the DNA-PKcs protein remains problematic. We have developed an in vitro assay that is
preferentiallyactiveforDNA-PK-independentDSBrepairbasedsolelyonitsreactionconditions,facilitatingcoincidentdiﬀerential
biochemical analysis of the two pathways. The results indicate the biochemically distinct nature of the end-joining mechanisms
represented by the DNA-PK-dependent and -independent NHEJ assays as well as functional diﬀerences between the two pathways.
1.Introduction
DNA double-strand breaks (DSBs) constitute the most
cytotoxic form of DNA damage in the genome. DSBs are
generated not only by exogenous sources, such as ionizing
radiation, radiomimetic compounds, and topoisomerase
inhibitors but also from endogenous cellular processes that
generate reactive oxygen species [1, 2]. In mammalian
cells, one of the major pathways for the repair of DSBs is
nonhomologous end joining (NHEJ) [3, 4]. The principle
proteins that participate in this DNA end joining pathway
both in vitro [5–7]a n din vivo [8–10] are the Ku 70/80
heterodimer, DNA-PKcs, XRCC4, DNA ligase IV and XLF
(XRCC4-like factor; also called Cernunnos) that has recently
been identiﬁed as a binding partner of the DNA ligase IV-
XRCC4 complex and as necessary for eﬃcient ligation via
NHEJ [11, 12]. Subsets of NHEJ may involve other factors
such as Artemis [13]. Together with the Artemis protein,
DNA-PKcs can stimulate processing of the DNA ends [14,
15]. Additional proteins, including DNA polymerases μ and
λ , TDP1 (tyrosyl-DNA phosphodiesterase), PNK (polynu-
cleotide kinase), and WRN (Werner’s syndrome helicase) are
also likely to play a role in DSB repair [16]. Recent reports
suggest that numerous other proteins, including ATM, his-
tones H1 and H2AX, NBS1, and Mre11 may also have some
inﬂuence on the NHEJ pathway [17–19]. NHEJ is a complex,
multistep process initiated by the binding of a heterodimeric
complex composed of Ku70 and Ku80 subunits (encoded
by the XRCC5 and XRCC6 genes, respectively) to both
ends of the broken DNA molecule with high speciﬁcity and
aﬃnity [20]. Ku binds DNA DSB ends and recruits DNA-
PKcs, which is a 460kDa serine/threonine protein kinase, to
the ends [21]. Ku then translocates inward, approximately
14bp on the DNA, allowing DNA-PKcs to contact DNA [22].2 Journal of Nucleic Acids
The resulting DNA-PK holoenzyme (Ku/DNA-PKcs) has a
serine/threonine protein kinase activity that is necessary for
eﬃcient repair [23]. A current model of NHEJ suggests that
inward translocation of Ku allows DNA-PKcs molecules on
opposing DSB ends to interact across the DSB and form a
molecular “bridge” or synapse between the two DNA ends
[24], and end-joining may then be completed by ligation of
the DNA ends by DNA ligase IV/XRCC4/XLF complex [25].
Therefore, DNA-PK has important roles in NHEJ that
include its DNA end-bridging activity [24], and its function
in regulating DSB end processing enzymes, such as the
structure-dependent nuclease Artemis [15] and its require-
mentforthestablerecruitment ofthe DNAligaseIV/XRCC4
complex [26]. In support of this DNA-PK-dependent NHEJ
model, previous studies have shown that DNA-PK binds
XRCC4-ligase IV [26, 27], but not the other mammalian
DNA ligases (I or III) in vitro [28]. It has also been
shown that wortmannin, a chemical inhibitor of DNA-PK,
[29] inhibits NHEJ [5] in a way similar to that seen in
cells expressing kinase deﬁcient DNA-PKcs [23]. However,
the role of DNA-PK kinase activity in NHEJ has not yet
been fully understood. Although DNA-PKcs binds to Ku
at DNA DSB sites, disruption of these DNA-PK complexes
by autophosphorylation [30, 31] is required for subsequent
ligation of the DNA ends [32, 33]. It has been established
that DNA-dependent protein kinase (DNA-PK) undergoes a
series of autophosphorylation events that facilitate successful
completion of nonhomologous end joining [32]. DNA-PKcs
isphosphorylatedatmultiplesitesinvivoinresponsetoDNA
damage, including serine 2056 [34], a cluster of sites between
residues 2609–2647 (referred to as the ABCDE or Thr-2609
cluster), and threonine 3950 [35]. Although DNA-PKcs in
which the ABCDE sites have been mutated to alanine has
normal protein kinase activity, its ability to dissociate from
the Ku-DNA complex is reduced in vitro [36]a n din vivo
[37], suggesting that phosphorylation of the ABCDE sites
plays a major role in regulating disassembly of the initial
DNA-PK complex. DNA-PK also phosphorylates the Ku
subunits [38] and XRCC4 [39], but mutation of these phos-
phorylation sites does not inhibit NHEJ [26, 40]. It has been
suggested that activation of the kinase may be required for
mobilizationoftheDNAligaseIV/XRCC4complex[41],but
themechanismformobilization is unknown. Ithas alsobeen
suggested that phosphorylation of histone H1 by DNA-PK,
which reduces the aﬃnity of the histone for DNA is required
for NHEJ [42]. Alternatively, it has also been proposed that
DNA-PKcs stimulates, but is not essential to, NHEJ [10, 18].
Recent studies have revealed the overall structural architec-
ture of DNA-PKcs and Ku with DNA under conditions that
mimic DSBs and DNA-PKcs autophosphorylation [43]. The
results indicate that eﬃcient association and dissociation of
the DNA-PKcs at DSBs is regulated by Ku and DNA-PKcs
autophosphorylation that induces dramatic conformational
changes in the protein. Recently, a three-dimensional crystal
structure of puriﬁed DNA-PKcs in complex with C-terminal
fragments of Ku80 has been determined and reveals irregular
r e g i o n so fr e p e t i t i v es t r u c t u r e s( α-helical HEAT repeats)
that might provide a ﬂexible cradle to promote DNA DSB
repair [44]. Conceivably, individual phosphorylation events
have diﬀerent eﬀects on DNA-PKcs structure and function,
both in vitro and in vivo, which in turn inﬂuences the
assembly and disassembly of the initial NHEJ complex
that regulates the accessibility of the DSB to other repair
f a c t o r sa sw e l la sp a t h w a yp r o g r e s s i o n[ 3, 33, 45]. The
DNA-PK dependent pathway could thus be characterized
as the principle NHEJ pathway that employs the products
of DNA-PKcs, Ku70/80, DNA ligase IV, XRCC4, XLF, and
Artemis. Defects in the components of this pathway have
been implicated in genomic instability and development of
cancer [46, 47]. The possibility however of the presence
of alternative pathways for NHEJ was suggested by early
experiments in which cells deﬁcient in DNA-PKcs, Ku, DNA
ligase IV, or XRCC4 showed a high potential of end joining
with preferential use of microhomologies [48]. The presence
of at least one alternate pathway was ﬁrst indicated by the
observationthatDNA-PKmutantMO59Jcells,whichdonot
express DNA-PKcs, retain the ability to repair DNA DSBs
[8] and exhibit wild-type end-joining activity in vitro [49],
suggesting the involvement of a DNA-PK-independent end-
joiningpathwayinthesecells.AtleasttwoNHEJmechanisms
have also been identiﬁed in cells with DNA-PKcs in vivo:a n
immediate, high-ﬁdelity end joining that occurs within two
hours, followed by an error-prone DSB repair with slower
kinetics [49,50].A study of celllines with andwithout DNA-
PKcs, M059K, and M059J, respectively, suggests that the ﬁrst,
faster NHEJ pathway is DNA-PKcs-dependent and the sec-
ond, slower NHEJ pathway is DNA-PKcs-independent [51,
52]. DNA-PK-dependent and -independent repair has also
been indicated in vivo a saf u n c t i o no fc e l lc y c l e[ 53]. Recent
studies have conﬁrmed the operation of alternative pathways
of NHEJ in the absence of the DNA-PK/LigIV/XRCC4
complex, in which another ligase partially substitutes for
DNA ligase IV [54, 55]. Although Polβ, XRCC1, PARP-
1, and DNA ligase III contribute predominantly to base
excision repair (BER) and SSB repair [56], these proteins
are also considered to be candidate components for backup
pathways for NHEJ in which ligase III provides the major
ligation activity [57, 58]. Indeed, PARP-1 has been shown
to compete with Ku for repair of DNA double-strand
breaks but apparently through distinct NHEJ pathways [59].
These backup pathways are not typically detectable in the
presence of DNA-PKcs, suggesting that the binding of the
protein to the DNA inhibits DNA-PK-independent NHEJ
[49, 54]. A more recent work has identiﬁed histone H1 as an
additional putative factor that operates preferentially within
these backup pathways [60]. Although there is a signiﬁcant
evidence in vivo and in vitro of a DNA-PKcs-independent
NHEJ pathway, this DNA end-joining mechanism has only
been reported in vitro in the absence of the kinase subunit
duetotheapparentinhibitionofalternatepathwaysbyDNA-
PKcs [54] .I nt h i ss t u d y ,w eh a v ei d e n t i ﬁ e din vitro reaction
conditions that optimize the repair of DNA DSBs via a
DNA-PK-independent pathway in the presence of functional
DNA-PKcs.WealsoevaluatedDSBend-joiningeﬃciencyand
DNA-PKactivityinextractstreatedwithwortmannin,which
is a potent and selective inhibitor of phosphatidylinositol 3-
kinases (PI3K) as well as the PI3K-like DNA-PK and has a
pronounced eﬀect on DNA DSB repair [61, 62]. Under theseJournal of Nucleic Acids 3
same conditions, we have found that DNA-PK is active in
the absence of wortmannin and inhibited in the presence of
wortmannin but that inhibition of DNA-PK’s kinase activity
does not inhibit NHEJ. Results also conﬁrm that under
reaction conditions that favor DNA-PK-dependent NHEJ,
wortmannin completely inhibits DNA end joining. We have
found that the individual activities of the two NHEJ repair
pathways are diﬀerentially aﬀected by reaction conditions.
Furthermore, as evidenced in earlier studies [49, 50], we
have observed decreased DSB repair ﬁdelity under reaction
conditions that favor DNA-PK-independent NHEJ.
2.MaterialsandMethods
2.1.Materials. T4DNAligase(10U/μL)waspurchasedfrom
Invitrogen (Carlsbad, CA.). Wortmannin was from Sigma
(St. Louis, MO). Restriction enzymes were from New Eng-
land BioLabs (Beverly, MA). Vistra Green was obtained from
AmershamBiosciences(Piscataway,NJ).AntibodiestoKu80,
XRCC4, GAPDH, PARP-1, histone H1 (IgG2a), DNA-PKcs,
and ATM were purchased from Abcam, Inc. (Cambridge,
MA). Antibodies to DNA ligase I, Mre11, Rad50, and NBS1
were from GeneTex, Inc. (San Antonio, TX). Antibodies to
DNA ligase III were from Novus Biologicals (Littleton, CO).
All antibodies were of isotype IgG1 except where noted. The
DNA-PK peptide substrate was purchased from Promega
(Madison, WI). Plasmid pSP189 was a gift from Dr. Michael
Seidman (National Institute of Aging, Baltimore, MD).
2.2. Cellular Extraction. Unless otherwise indicated, cervical
cancer (HeLa) cells, ﬁbroblast (WI-38) cells, and malignant
glioma (M059K) cells (8 × 107 cells/mL) were extracted by
triplicate rounds of freezing and thawing in B1 lysis buﬀer
(10mM HEPES pH 7.9, 60mM KCl, 1mM EDTA pH 8.0,
1mM DTT , and 1mM PMSF). L ysates were cleared by
centrifugation at 16,000 × g for 30min at 4◦C and the
supernatants constituting the WCEs were stored as aliquots
at −80
◦C.
2.3. DSB End-Joining Assays. Reactions (50μL; 50mM Tris-
HCl, pH 7.6, 5mM MgCl2, 1mM DTT, 1μg/mL aprotinin,
1μg/mL leupeptin, 10μg/mL bestatin, 1mM pefabloc, 1mM
ATP, 100ng StuI-cut pSP189 plasmid DNA unless otherwise
indicated, and with or without 5% (w/v) polyethylene glycol,
MW ∼8kDa, ((PEG) also where indicated) were initiated
with the addition of 15μg WCE. Reactions were incubated at
30
◦C for the times indicated. Experiments with wortmannin
werepreparedandincubatedonicefor10minbeforeheating
to 30
◦C. All reactions were stopped with the addition of
SDS (0.4%) and incubation at 65
◦C for 15min. DNA was
recovered by phenol: chloroform extraction and ethanol
precipitation, separated on 1% agarose gels, and stained
with Vistra Green for 1hr. Images were digitized with a
FluorImager 595 system and quantiﬁed densitometrically
using GelPro v2.0 software (Media Cybernetics, Gaithers-
burg, MD).
DSB repair ﬁdelity experiments employed a modiﬁcation
of the end-joining assay described above. Repair ﬁdelity was
measured as a function of restriction enzyme recleavage
eﬃciency for the end-joined DNA products recovered from
the assay described above. Standard end-joining reactions
were run with pSP189 DNA linearized with StuI, EcoRI,
PvuI, or Hin1I (producing blunt, 4 nucleotide 5 -overhang,
2n u c l e o t i d e5  -overhang, or 2 nucleotide 3 -overhang DSB
ends, respectively). DNA recovered from these reactions in
the ethanol precipitation step was redissolved in 20μLo f
the appropriate manufacturer’s restriction enzyme reaction
buﬀer and split into two 10μL aliquots. One aliquot was
incubated at 37
◦C for 2h with 2.5U of the restriction
enzyme originally used to linearize the plasmid. Following
this redigestion step, both aliquots were electrophoresed and
analyzed as described above for the end-joining assay. All
DSB repair ﬁdelity reactions were run in triplicate.
2.4. Kinase Assays. Kinase activity was assayed under the
same conditions as DNA end joining, except for the addi-
tion of 5μg peptide substrate (EPPLSQEAFADLWKK) and
0.2μCi [γ- 32P] ATP. Reactions were incubated at 30
◦Cf o r
10min then quenched as described for the end-joining assay.
The peptide substrate was isolated on 16% Tris-Tricine SDS
PAGE gels and analyzed by autoradiography.
2.5. Immunodepletions. WCE (700μg) was incubated with
antibody(70μg)for1hronice.Antibody-boundproteinwas
removedbyadding eitherSepharoseA orGin binding buﬀer
(50mM Tris-HCl, pH 7.6; 0.1mg/mL BSA), and rotating for
1hrat4 ◦C. Unbound proteins were recovered by ﬁltration
through a 0.22μm cellulose acetate membrane and stored at
–80
◦C. Target protein depletion was conﬁrmed by western
blot, following 4–12% Tris-Glycine SDS gradient PAGE.
Immunodepletion of DNA ligase IV was performed using
antibodies to XRCC4 due to the lack of ligase IV-speciﬁc
antibodies. It has been reported that only trace ligase IV is
found unbound to XRCC4 due to the instability of free DNA
ligase IV [63]. In our hands, immunodepletion of XRCC4
resulted in nearly complete removal of the ligase.
3. Results and Discussion
3.1. Determination of Preferential Reaction Conditions for
DNA-PK-Dependent, and DNA-PK-Independent Nonhomol-
ogous End-Joining Pathways. In previous studies, both DNA-
PK dependent and independent NHEJ pathways have been
observed in vivo [5, 49–51, 58], however, no in vitro reaction
conditions in the presence of a functional DNA-PKcs protein
have been reported to date that favor DNA-PK-independent
DNA end joining. Several studies have noted the role of
polymers such as PEG in stabilizing and enhancing the
binding of proteins to the DNA through a macromolecular
crowding eﬀect [64]. Earlier works had shown that in the
presence of high concentrations of macromolecules such as
PEG, T4 DNA ligase as well as DNA ligase preparations
from rat liver nuclei or from Escherichia coli actively catalyze
blunt end ligations, in contrast to the poor activity of
these enzymes on such substrates under conventional assay
conditions [65]. These and other studies have argued that4 Journal of Nucleic Acids
suchmacromolecularcrowdingorconﬁnementmayperhaps
play a more essential role in cell biology and physiology than
otherwise noted and could well be a more adequate model
for intracellular, in vivo conditions [66].
We observe that, in the presence of 5% polyethylene
glycol (PEG), DNA end joining is insensitive to wortmannin,
a potent and selective inhibitor of DNA-PK [29] that
covalently binds to the protein. Whole cell extracts (WCE)
from HeLa, WI-38, and M059K cells were assayed for
DNA end-joining activity with and without 5% PEG and
10μM wortmannin. The WCEs were assayed for the ability
to end-join blunt-end StuI-cut plasmid DNA (which we
have previously shown to be NHEJ-dependent [67]) and
produce plasmid dimers and trimers that were detected on
agarose gels stained with Vistra Green (Figure 1(a)). After
2hrs at 30
◦C in the absence of PEG, the WCEs generated
5 to 25% product, depending on cell type (Figure 1(b)).
The same reactions run with 10μM wortmannin reduced
the total amount of product to between 0 to 4%, also
depending on cell type. The assay was repeated in the
presence of 5% PEG, resulting in 12 to 24% product in
the absence of wortmannin. For HeLa and WI-38 WCEs,
product yield increased up to 2-fold with the addition
of PEG, while addition of 10μM wortmannin resulted in
little or no decrease in product. However, an approximately
60% decrease in product was observed with M059K WCE
in the presence of PEG and wortmannin, which though
signiﬁcantly less than the wortmannin inhibition observed
with this extract in reactions without PEG still indicated that
a fraction of the NHEJ was wortmannin-sensitive even in the
presenceofPEG.Itcouldbearguedthataresidualamountof
the end-joined product is due to DNA-PK-dependent NHEJ
or that alternatively, DNA-PKcs may be playing a structural
and/or stimulatory role in the organization of the initial
NHEJ complex [43].
The end-joining reactions were repeated with HeLa
WCE, 1% DMSO, and 0.1 to 10μM wortmannin in 1%
DMSO (Figure 2(a)). Complete inhibition of DNA end
joining was observed in the absence of PEG with 1.5μM
wortmannin. In contrast, in the presence of 5% PEG, only
a1 5t o2 0 %r e d u c t i o ni np r o d u c tw a so b s e r v e dw i t h1 . 5μM
wortmannin. No further inhibition was observed with up to
10μMwortmannin.Todeterminetheeﬀectiveconcentration
of PEG required to favor wortmannin-insensitive NHEJ,
the DNA end-joining assay was repeated for 1hr at 30
◦C
with 0 to 5% PEG with and without 10μM wortmannin
(Figure 2(b)). In the absence of wortmannin, a steady
increase in product formation was observed with the addi-
tion of up to 4% PEG, after which, a trend towards a small
decrease in product formation was observed. Conversely, in
the presence of wortmannin, a minimum of 3% PEG was
required for the generation of end-joined product and at
5% PEG, little or no wortmannin inhibition was observed.
Presumably, at a concentration of 5% PEG, the product
is being formed by a wortmannin-insensitive, DNA-PK-
independent NHEJ pathway.
It has been reported previously that blunt-ended DNA
activates DNA-PK less eﬃciently than DNA DSBs with 3 -o r
5 -overhangs[68].Therefore,wewishedtoconﬁrmDNA-PK
activity under our end-joining reaction conditions in the
absenceofPEGandwortmanninandalsodeterminewhether
thelossofwortmanninsensitivityinthepresenceofPEGwas
due to the operation of a DNA-PK-independent pathway or
simply due to the inability of wortmannin to inhibit DNA-
PK in the presence of PEG. DNA-PK kinase activity was
assayed under the same reaction conditions as those used for
theend-joiningassays(Figure 2(c)).R eactionswereprepared
in the same manner as the DNA end-joining reactions,
but with the addition of 5μgo fap e p t i d eD N A - P K -
phosphorylation substrate and [γ- 32P] ATP. The reactions
were prepared with and without DNA, 5% PEG, and 10μM
wortmannin, and incubated at 30
◦Cf o r5m i n u t e s .A si s
typical with the peptide substrate-based DNA-PK activity
assay, nonspeciﬁc background kinase activity is observed for
samples in the absence of added activator DNA, regardless
of the presence or absence of PEG. A 2.5- to 3-fold DNA-
dependent increase in kinase activity was observed following
addition of the blunt-ended end-joining substrate DNA, and
no diﬀerence in activity was observed between reactions
with and without PEG. The addition of 10μM wortmannin
inhibitedalldetectablekinaseactivityinbothreactions,indi-
cating that the PEG did not aﬀect the ability of wortmannin
to inhibit DNA-PK kinase activity. Therefore, PEG did not
inhibit DNA binding, kinase activation, or wortmannin-
mediated inhibition of DNA-PK. Consequently, even though
DNA-PK kinase is active in the presence of PEG, DNA end
joining seems to be independent of this kinase activity, since
addition of 10μM wortmannin, which completely inhibits
kinaseactivity,doesnotinhibitNHEJinthepresenceofPEG.
Thus,inthepresenceof5% PEG, invitro reactionconditions
are established in which the NHEJ proceeds via a DNA-PK-
independent pathway or at least one that is independent of
the kinase activity of DNA-PK. This result argues for a much
broader role for DNA-PK in the context of the structural
architecture of the initial NHEJ complex in addition to the
role it plays in catalyzing phosphorylation of several other
repair proteins [43, 44].
3.2. Survey of Proteins Involved in DNA-PK-Dependent and
-Independent Nonhomologous End Joining. We wished to
determine the contribution of individual proteins to either
of the two NHEJ pathways. To this end, a variety of proteins
were individually immunodepleted from the HeLa WCE
and DNA end-joining assays were conducted (with and
without 5% PEG) to detect depletion-dependent reductions
inend-joiningactivity(Figure 3).ImmunodepletionofKu80
and DNA ligase IV resulted in an almost complete loss
of DNA end-joining eﬃciency for reactions both in the
presence or absence of 5% PEG. This supports our earlier
observations [69] and indicates the indispensable role that
Ku plays in the initial recognition and binding of DSB
ends and that of ligase IV in the ﬁnal ligation step of the
NHEJ process. Immunodepletion of NBS1 and histone H1
resulted in a signiﬁcant loss of DNA-PK-dependent DNA
end-joining activity in reactions without PEG (Figure 3(a)).
In comparison, in reactions with 5% PEG, only a min-
imal loss of presumed DNA-PK-independent activity was
observed with immunodepletion of NBS1 and histone H1Journal of Nucleic Acids 5
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Figure 1: DNA end joining with HeLa, WI-38, and M059K WCEs with and without 5% PEG and/or 10μM wortmannin. (a) Agarose gel
image showing typical DNA end-joining reaction results. Dimer and trimer DNA end-joining product yields are calculated as a fraction of
the total DNA in the lane and reported graphically as shown in panel B. (b) Graphical depiction of results for triplicate end-joining reactions
run with the three cell extracts under each of the conditions indicated. Error bars indicate the standard deviation for triplicate reactions.
Signiﬁcant diﬀerences, as determined by the Student t-test, are indicated by an asterisk. The P-values for each pairing are given above the
brackets.
(Figure 3(b)). This is an interesting result in the context
of the supposed stimulatory role of NBS1 and histone
H1 in the backup pathways of NHEJ, where histone H1
enhances the activity of both DNA ligase III and PARP-
1[ 60]. Immunodepletion of DNA-PKcs resulted in a 30%
reduction in the eﬃciency of the end-joining reactions
without PEG, with little reduction observed in the presence
of PEG. In addition, immunodepletion of Poly (ADP-
ribose) polymerase 1 (PARP) and DNA ligase III consistently
resulted in a trend toward increased eﬃciency for both
the presumed DNA-PK-dependent and -independent NHEJ
over the course of multiple experiments. This observation
suggests the operation of backup pathways under these
conditions and supports the hypothesis that these proteins
may compete for repair at the DSB ends through alternate
NHEJ pathways [58, 59]. Perrault et al. reported that
DNA-PK independent DNA end joining is observed after
immunodepletion of DNA-PKcs [54]. To conﬁrm that the
DNA end joining observed after immunodepletion of DNA-
PKcs is actually DNA-PK-independent, the immunodepleted
extract was assayed for activity with and without 10μM
wortmannin (Figure 3(c)). End joining by the WCE was
inhibited in the presence of 10μM wortmannin; whereas
the DNA end-joining activity of the DNA-PKcs immun-
odepleted extract was wortmannin-insensitive, indicating
that a DNA-PK-independent process formed the prod-
uct.
Fromanexaminationoftheimmunodepletiondata,only
Ku and ligase IV-XRCC4 complex could be speciﬁcally iden-
tiﬁed as participating in the DNA-PK-independent NHEJ in
this system, while Ku, DNA-PKcs, ligase IV-XRCC4, NBS1,
and histone H1 are implicated in the DNA-PK-dependent
NHEJ. These results support a previous model proposed
by Riballo et al., in which one pathway consists of Ku and
ligase IV-XRCC4 that can be stimulated by DNA-PKcs,a n d
a second, DNA-PKcs-dependent pathway that requires NBS1
[18].
3.3. The In Vitro DNA-PK-Dependent and -Independent Non-
homologous End-Joining Pathways Exhibit Diﬀerent Optimal
Reaction Conditions.. S e v e r a lg r o u p sh a v er e p o r t e din vitro
assays for DNA DSB repair but reaction conditions diﬀer
considerably. To investigate if reaction conditions could be
established for the end-joining assay that favor one pathway
over the other, we tested the DNA end-joining activity of
HeLa WCE with and without 5% PEG under a variety of
reaction conditions. Two separate buﬀers were used. Buﬀer
A is composed of 50mM Tris-HCl, pH 7.6, and 75mM
KOAc along with 5 mM MgCl2, 1mM DTT, and a protease
inhibitor cocktail. Buﬀer B includes bis-tris-propane, pH
8.2, and 75mM KCl with 5mM MgCl2, 1mM DTT, and
a protease inhibitor cocktail as before (see Materials and
Methods for details). DSB end joining with HeLa WCE
under these two conditions were measured over time with
and without 5% PEG. In the absence of PEG, buﬀer A
produced a small but consistently higher yield of DNA end-
joining products over time compared to reactions in buﬀer
B, and under both conditions, a linear increase in product
was generated during the ﬁrst 5 hours (data not shown).
With PEG, an increase in end joining was observed with
buﬀer B compared to buﬀer A (Figure 4(a)). However, under
both conditions, product formation appeared to plateau
after about 3 hours. Buﬀer A therefore, seemed to provide
the most optimal reaction conditions for the DNA-PK-
dependent (without PEG) end-joining whereas Buﬀer B
seemed to provide the same for the DNA-PK-independent
(with PEG) end-joining pathway in our system.
This observation was also reported by Ramsden et al.,
who demonstrated a modest increase in Ku-dependent
ligation of DNA lacking DNA-PKcs on increasing the6 Journal of Nucleic Acids
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Figure 2: DNA end-joining activity and DNA-PK activity responses in PEG and/or wortmannin. (a) Wortmannin dose response. DNA end-
joiningreactionswererunusingHeLaWCEunderstandardconditionswithorwithout5%PEGandwortmanninfor1hrat30
◦C.Reactions
contained 0 to 10μM wortmannin in 1% DMSO. Error bars indicate the standard deviation for triplicate reactions. (b) PEG dependence of
wortmannin sensitivity. DNA end-joining reactions were run in triplicate with and without 10μM wortmannin at 0–5% PEG. (c) DNA-PK
kinase activity under DNA end-joining reaction conditions in the presence and absence of PEG. Standard DNA end-joining reactions were
run with HeLa WCE for 10 min at 30
◦C in the presence of a DNA-PK peptide substrate and [γ-
32P] ATP. The peptide was isolated on a 16%
PAGE gel and the intensity of the radiolabeled band, a measure of DNA-PK kinase activity, was detected by autoradiography. The presence
or absence of 5% PEG during the end-joining reaction did not aﬀect DNA-PK kinase activity, nor did it aﬀect the ability of wortmannin to
inhibit DNA-PK kinase activity. The mean activity of duplicate reactions is plotted.
concentration of KCl from 25mM to 120mM [70]. High
concentrations of chloride have been reported earlier to
reduce protein-DNA interactions [71, 72]. Of the NHEJ
proteins, only Ku can bind directly to DNA in 75mM
KCl [73]. However, since both the NHEJ-dependent and -
independent pathways utilize Ku, a reduction in the number
of nonspeciﬁc protein-DNA interactions competing with Ku
for the DNA ends should enhance both NHEJ pathways.
However, high-chloride concentrations can also inhibit
protein-protein interactions and have indeed been shown to
inhibit DNA-PK holoenzyme formation [72, 74].
Variable concentrations of the divalent cations Mg2+
and Mn2+ were also examined for their eﬀect on DNA
end-joining activity. Increasing MgCl2 concentration from
its optimum at 5mM, up to a ﬁnal concentration of 10mM
(by steps of 1, 2, and 5mM additions of MgCl2) had little
eﬀect on DNA end-joining activity with or without PEG
(datanotshown).Additionofupto5mMMnCl2 inaddition
to the 5mM MgCl2 already in the standard reaction buﬀers,
increased DNA-PK-dependent end-joining activity (without
PEG) and reduced DNA-PK-independent end joining (with
PEG) (as shown in Figure 4(b)). To further study the eﬀect
of manganese on DNA end joining, various concentrations
of MnCl2 were added to reactions with 5% PEG and 10μM
wortmannin (Figure 4(c)). As observed previously in the
absence of MnCl2 and presence of PEG, a small decrease
in DNA end-joining activity occurred with the addition
of 10μM wortmannin. Without wortmannin, DNA end-
joining activity was reduced at low MnCl2 concentrations
but partially recovered with the addition of 0.5 to 1mM
MnCl2. This recovery in activity, however, was inhibited
by wortmannin, indicating that even in the presence ofJournal of Nucleic Acids 7
0
2
4
6
8
10
12
14
16
18
K
u
8
0
D N
A
-
P K c s
L
i
g
a
s
e
I
L
i
g
a
s
e
I
I
I
L
i
g
a
s
e
I
V
M
r
e
1
1
R
a
d
5
0
N
B
S
1
A
T
M
P
A
R
P
1
H
i
s
t
o
n
e
H
1
Control WCE
Immunodepleted WCE
(−)P E G
D
N
A
e
n
d
j
o
i
n
i
n
g
(
%
)
(a)
0
5
10
15
20
25
30
35
40
K
u
8
0
D
N
A
-
P
K
c
s
L
i
g
a
s
e
I
L
i
g
a
s
e
I
I
I
L
i
g
a
s
e
I
V
M
r
e
1
1
R
a
d
5
0
N
B
S
1
A
T
M
P
A
R
P
1
H
i
s
t
o
n
e
H
1
D
N
A
e
n
d
j
o
i
n
i
n
g
(
%
)
Control WCE
Immunodepleted WCE
(+) PEG
(b)
L
−
ID WCE
Wortmannin ++ −− −
−
(c)
Figure 3: DNA end joining with immunodepleted extracts. HeLa WCE was immunodepleted for the various potential NHEJ proteins
indicated, and immunodepletion (≥3-fold) of the target protein was conﬁrmed by western blot (data not shown). The individual
immunodepleted extracts were then assayed for DNA end-joining activity at 30
◦C for 2 hrs. (a) Results of DNA end-joining reactions
performed in the absence of 5% PEG. (b) Results of DNA end-joining reactions performed in the presence of 5% PEG. All reactions were
performed in triplicate and error bars indicate the standard deviation. (c) Wortmannin-insensitive DNA end joining is detectable in the
DNA-PKcs immunodepleted HeLa WCE in the absence of PEG. Reactions were run in the absence of 5% PEG and where indicated, in the
presence of 10μM wortmannin at 30
◦C for 2hrs.(L) T4 DNA ligase positive control; (−)negative control; (ID)DNA-PKcs-immunodepleted
WCE.
5% PEG, a small fraction of the observed DNA end-joining
activity results from the DNA-PK-dependent pathway or at
least one that is dependent on the DNA-PK kinase activity.
Furthermore, the addition of MnCl2 increases the activity
of this wortmannin-sensitive pathway. Previous studies have
shown that one factor that could alter the relative inﬂuence
of a particular end-joining pathway in the reaction is the
concentration of divalent cations, particularly Mg2+ and
Mn2+ [75]. We observe that the DNA-PK-dependent NHEJ
activity present in our system is sensitive to the reaction
concentration of Mg2+ and particularly, Mn2+. Elevated
concentrations of these divalent cations stimulate overall
end-joining activity and mask the requirement for DNA-
PK, suggesting the involvement of a DNA-PK-independent
NHEJpathway.Thus,therelativecontributionofaparticular
pathwaytotheoverallend-joiningactivityobservedinWCEs
seems to depend on, and in turn reﬂect, the in vitro reaction
conditions used. Taken as a whole, diﬀerential reaction
buﬀer preference and variable responses to divalent cations
observed in this study emphasize the existence of distinct
biochemical diﬀerences between the DNA-PK-independent
and-dependentNHEJactivitiesobservedinthepresenceand
absence of PEG, respectively.
3.4. Functional Changes Are Associated with DNA-PK-
Dependent and -Independent Reaction Conditions. Previous
studies have suggested that DNA-PK-dependent and -
independent repair pathways may be functionally distinct,
possibly preferentially interacting with certain subclasses of
DNA DSBs and/or having diﬀerent DSB repair ﬁdelity [18,
49–51, 58]. We therefore chose to investigate DSB repair
ﬁdelity under our DNA-PK-dependent and -independent
reaction conditions. To test DSB repair ﬁdelity, the ability
of the HeLa WCE to accurately end-join DSBs with various
DSB-endoverhangconﬁgurationswasdetermined. Standard
DNA end joining assays run both with and without 5%
PEG were conducted using substrate plasmid DNA that had
been linearized by restriction digestion with, StuI (blunt
ends),EcoRI(4nucleotide5 -overhang),Hin1I(2nucleotide
5 -overhang), or PvuI (2 nucleotide 3 -overhang). The
products of these end-joining reactions were then subjected
to redigestion with their corresponding restriction enzyme
(Figure 5). Accurate DSB end-joining restores the enzyme
recognition sequence at the end-joining junction sites,
resulting in product DNA that is susceptible to recutting
with the restriction enzyme originally used to linearize the
plasmid. DSB repair ﬁdelity is deﬁned as the frequency
with which the DNA end-joining assays accurately join
DSB ends, and is reported here as the percent of total
end-joined product DNA cleaved following redigestion with
the appropriate restriction enzyme. As shown in Figure 5,
substantialfunctionaldiﬀerencesweredetectedbetweenDSB8 Journal of Nucleic Acids
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Figure 4: Eﬀects of reaction conditions on DNA end-joining activity. (a) Reaction buﬀer composition eﬀects on HeLa WCE end-joining
activity time course reactions in the presence of 5% PEG. Reactions were run at 30
◦C for the times indicated in either of the two standard
reaction buﬀers as described in the text. The mean values of triplicate reactions were plotted and the error bars indicate standard deviation.
(b) Eﬀects of MnCl2 on HeLa WCE DNA end-joining activity. Reactions were run with the addition of 0–5mM MnCl2 to standard DNA
end-joining reactions containing 5mM MgCl2 f o r2h r sa t3 0
◦C in the presence or absence of 5% PEG as indicated. (c) The DNA end-joining
reactions employing MnCl2 (0–5mM) in the presence of PEG were repeated with and without 10μM wortmannin (6hrs at 30
◦C). Reactions
were run in triplicate and the error bars indicate standard deviation.
repair reactions catalyzed by the DNA-PK-dependent and
-independent NHEJ pathways. End joining under DNA-
PK-dependent reaction conditions (without PEG) resulted
in substantially higher DSB repair ﬁdelity than reactions
(with PEG) favoring the DNA-PK-independent end-joining
pathway, and these results are consistent with the pathway-
dependent DSB repair ﬁdelity reported by others [51].
4. Conclusion
In summary, we have demonstrated in vitro assay conditions
that permit coincident and diﬀerential analysis of DNA-PK-
dependent and -independent NHEJ activities under condi-
tions in which functional DNA-PKcs is present. Establishing
anddeﬁningthesereactionconditionsfacilitatesbiochemical
analysis of these important subpathways of NHEJ regardless
of the cellular source of enzyme activities, and irrespective
of intrinsic DNA-PKcs expression status. We found that
reactions containing 5% PEG favored DNA-PK-independent
NHEJ while reactions lacking PEG favored DNA-PK-
dependent NHEJ. The biochemically distinct nature of the
pathways represented by these two reaction conditions is
borne out by the diﬀerential end-joining activity observed in
response to the DNA-PK inhibitor wortmannin, immunode-
pletion of individual proteins that may participate in NHEJ,
and the pathway speciﬁc responses to divalent cations, and
reaction buﬀer composition.
In addition to these results that indicate the bio-
chemically distinct nature of the end-joining mechanisms
represented by the DNA-PK-dependent and -independent
NHEJ assays, we also observe functional diﬀerences between
the two pathways. We ﬁnd that DNA-PK-dependent DSB
end joining is a higher ﬁdelity process than DNA-PK-
independent end joining. This latter ﬁnding is consistent
with in vivo results reported by others using cell lines that
lack expression of DNA-PKcs [51, 52, 54], or following
depletion of DNA-PKcs from extracts of cells that do express
the protein [54].
In vitro end joining of restriction enzyme-cut plasmid
D N Ai sr o u t i n e l yr e p o r t e da sam e a s u r eo fN H E Ja c t i v i t y ,
yet these reports are often conﬂicting with respect to what
enzymes are involved in the repair of DNA DSBs. OurJournal of Nucleic Acids 9
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Figure 5: DNA end-joining ﬁdelity reactions run in the presence or
absenceof5%PEG.DNADSBendjoiningwasperformedwitheach
of the four diﬀerent restriction enzyme linearized plasmid DNA
substrates indicated to assess the eﬀects of diﬀerent DSB overhang
conﬁgurations (see text) upon the ﬁdelity of DSB repair occurring
under DNA-PK-independent and -dependent reaction conditions.
DSB repair ﬁdelity is measured as the fraction of total DNA end-
joining reaction products that are capable of being recut with the
restriction enzyme that was originally used to linearize the end-
joining substrate DNA. All reactions were run in triplicate. Bars
represent the average restriction enzyme redigestion eﬃciency of
the end-joining reaction products, which is reported as % ﬁdelity.
results indicate that multiple pathways may simultaneously
contribute to the production of linear plasmid multimers in
vitro. Consequently, the ability to selectively shift the mecha-
nism of product formation by altering reaction conditions
not only suggests the need for care when evaluating data
obtained by the wide variety of in vitro DSB repair assays
currently in use, but also provides a means by which greater
control may be achieved over the repair mechanism through
which this end point is reached.
Application of the reaction conditions described in this
report may permit concurrent investigations of the rela-
tive contributions of DNA-PK-dependent and -independent
NHEJ pathways to DSB repair in any mammalian cell. This
approach could be helpful in identifying proteins involved
in the DNA-PK-dependent and -independent NHEJ DSB
repair subpathways, and characterizing their individual roles
in these multiprotein repair complexes. Information such as
thisislikelytobeusefulinidentifyingnewandmoreeﬀective
approaches for manipulating cellular DSB repair activity.
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